Advertisement

Topics

Novartis' Kisqali Receives Positive CHMP Opinion

05:21 EDT 23 Jun 2017 | FinanzNachrichten

BASEL (dpa-AFX) - Novartis (NVS) announced the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA has adopted a positive opinion recommending approval o...

Original Article: Novartis' Kisqali Receives Positive CHMP Opinion

NEXT ARTICLE

More From BioPortfolio on "Novartis' Kisqali Receives Positive CHMP Opinion"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Novartis
Novartis is the fourth largest pharmaceutical company in the world, based on annual sales, which are exceeded $36,000m in 2009. Founded in 1996, Novartis focuses of four main areas; pharmaceuticals, vaccines & diagnostics, generic medicines and biosi...